PMN vs VNO · P/E 4.8, $14.1M cap vs rev $921.3M
ProMIS Neurosciences Inc. (PMN) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
ProMIS Neurosciences Inc. (PMN) is a biotechnology company listed on US.
VNO (VNO) common stock.
PMN does not have a complete income-statement cache yet.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
PMN currently screens at market cap $14.1M and trailing P/E 4.8. VNO currently screens at market cap $0.
Not investment advice. Open the PMN and VNO stock pages for the full models.
Not investment advice.